Atlas Trials

Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily

Clinical trial NCT00002241 · UNKNOWN

Trial details

NCT number
NCT00002241
Sponsor
Merck Sharp & Dohme LLC
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.